New Immunotherapy Drug More Effective in Treating Melanoma
NYU Langone study finds that immunotherapy drug nivolumab is superior in efficacy and safety compared to ipilimumab when treating melanoma.
New Immunotherapy Drug Shows Promise Against Several Cancers
A study from NYU Langone’s Perlmutter Cancer Center shows an experimental drug may be effective in treating several types of late-stage cancers.
New Immunotherapy for Treating Advanced Lung Cancer
Dr. Jeffrey G. Schneider, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses a new treatment for advanced lung cancer.
New Inflammatory Syndrome in Children Linked to COVID-19
NYU Langone pediatrician Dr. Adam Ratner discusses what you should know about the emerging inflammatory syndrome seen in children with COVID-19.
New Intraoperative System Correctly Classifies Brain Tumors
Study led by NYU Langone’s Dr. Daniel A. Orringer combines optical imaging with artificial intelligence to diagnose brain tumors in real time.
New Investigators Expand Endocrinology Research Initiatives
NYU Langone’s growing endocrinology team is contributing to diabetes and obesity research that paves the way for more effective treatments.
New Leader in Brain Tumor Treatment & Research Named
Researcher and clinician Dr. Alexandra Miller has joined NYU Langone as chief of neuro-oncology and co-director of the Brain and Spine Tumor Center.
New Leader Named for Ophthalmology Education & Cornea Care
Dr. Christina Rapp Prescott joins NYU Langone as the Department of Ophthalmology’s vice chair for education and director of the cornea service.
New Leader Named for Perlmutter Cancer Center—Sunset Park
NYU Langone hematologist–oncologist Dr. Rami K. Daya is leading renowned cancer experts at Perlmutter Cancer Center’s new Sunset Park location.
New Liver Tumor Program Targets Liver Cancer
A new liver tumor program at Perlmutter Cancer Center is led by Dr. Theodore Welling and treats more than just liver and biliary cancers.